FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

60 letters match. Newest first.

  1. Empower Clinic Services, LLC dba Empower Pharmacy

    FDA warns Empower Pharmacy its compounded drugs missed outsourcing-facility conditions, including labeling and adverse-event reporting.

    Medium
  2. Walfer Corporation dba The Medicine Shoppe Pharmacy

    FDA warned The Medicine Shoppe Pharmacy in Port Charlotte, Florida, over insanitary compounding conditions, vermin, and drugs made without valid prescriptions.

    High risk
  3. AnazaoHealth Corporation

    AnazaoHealth Corporation compounded drugs without meeting 503B conditions, including inadequate adverse event reporting.

    Medium
  4. Pharmaceutical Care Solutions dba Pharmacy Solutions

    FDA warns Pharmaceutical Care Solutions dba Pharmacy Solutions over compounded drugs made with ineligible bulk substances and lacking FDA approval.

    Medium
  5. Maitland Labs of Central Florida

    FDA warns Maitland Labs of Central Florida over sterile compounded drugs with manufacturing quality failures, mislabeling, and unapproved new drug violations.

    High risk
  6. Farmakeio Outsourcing LLC

    FDA warns Farmakeio Outsourcing over inadequate adverse event reporting and unapproved, misbranded compounded testosterone pellets.

    Medium
  7. MasterPharm LLC

    FDA warned MasterPharm over compounded Finasteride Plus capsules with excess finasteride, undeclared minoxidil, and insanitary aseptic conditions.

    High risk
  8. Joe Wise Pharmacy, Inc., dba Wise Pharmacy

    FDA warned Wise Pharmacy that its compounded sterile and non-sterile drugs were adulterated by insanitary compounding conditions.

    High risk
  9. American Specialty Pharmacy, Inc. dba ASP Cares

    FDA warned outsourcing facility ASP Cares about sterile compounded drugs made under insanitary conditions and with CGMP violations.

    High risk
  10. Hawaii Health Systems Corporation dba Kona Community Hospital Pharmacy

    Kona Community Hospital Pharmacy prepared sterile drugs in insanitary conditions with microbial contamination and facility flaws.

    High risk